Fig. 4
OS and DFS of XELOX and S-1 in N3. XELOX regimen showed significantly better efficacy compared to S-1 in N3 patients in terms of OS and DFS
Fig. 4 | BMC Cancer
OS and DFS of XELOX and S-1 in N3. XELOX regimen showed significantly better efficacy compared to S-1 in N3 patients in terms of OS and DFS